首页> 外文期刊>Pharmeuropa bio & scientific notes. >Collaborative study for the establishment of the 2nd International Standard for Bleomycin Complex A2/B2
【24h】

Collaborative study for the establishment of the 2nd International Standard for Bleomycin Complex A2/B2

机译:建立二号博莱霉素复合物A2 / B2国际标准的协作研究

获取原文
获取原文并翻译 | 示例
       

摘要

An international collaborative study was organised to establish the 2nd World Health Organization (WHO) International Standard (IS) for bleomycin complex A2/B2. Eight laboratories from different countries participated. Potencies of the candidate material were estimated by microbiological assays with sensitive micro-organisms. To ensure continuity between consecutive batches, the 1st IS for bleomycin complex A2/B2 was used as a reference. Based on the results of the study, the 2nd IS for bleomycin complex A2/B2 was adopted at the meeting of the WHO Expert Committee for Biological Standardization (ECBS) in 2014 with an assigned potency of 12 500 International Units (IU) per vial. The 2nd IS for bleomycin complex A2/B2 is available from the European Directorate for the Quality of Medicines & HealthCare (EDQM).
机译:组织了一个国际合作研究,建立了第二世界卫生组织(WHO)国际标准(IS)用于博来霉素A2 / B2。 来自不同国家的八个实验室参加。 通过微生物测定估算候选物质的疗效,具有敏感的微生物。 为了确保连续批次之间的连续性,第一个用于Bleomycin复合物A2 / B2作为参考。 根据该研究的结果,2014年世界卫生组织生物标准化(ECBS)的会议采用了第二次用于博来霉素复合物A2 / B2的博莱霉素复合物A2 / B2,其每名小瓶有1200个国际单位(IU)的指定效力。 第二型适用于博来霉素复合物A2 / B2可从欧洲药物和医疗保健质量(EDQM)获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号